Has Jordan Pinsker received payments from drug or device companies?

Yes. Drug and device makers reported $82,686 in general payments to Jordan Pinsker across 57 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jordan Pinsker did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jordan Pinsker come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jordan Pinsker

Pediatric Endocrinology · Santa Barbara, CANPI 1730138009

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $74,711 of the $82,686 with a category attached, or 90.4%. Tandem Diabetes Care, Inc. accounts for 85.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $53,621 and has fallen 99.8% since, to $101 in 2025. Among pediatric endocrinology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$82,686in general payments, 2019–2025

Across 57 payments — averaging $1450.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Tandem Diabetes Care, Inc.$71K
Eli Lilly$7K
Medtronic$5K
Dexcom, Inc.$54
Abbott$44
Lilly USA, LLC$8

$901,473in research payments, 2019–2025

Across 87 payments — averaging $10,362 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Insulet Corporation$743K
Medtronic$155K
Dexcom, Inc.$3K

What the payments were for

Consulting fees$74,71190%
Speaking & faculty fees$4,8006%
Travel & lodging$2,1583%
Food & beverage$1,0091%
Education$80%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Tandem Diabetes Care, Inc.	35	$70,740
Eli Lilly	3	$6,699
Medtronic	14	$5,141
Dexcom, Inc.	3	$54
Abbott	1	$44
Lilly USA, LLC	1	$8

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

t:slim X2 insulin pump$44,932
t-slim insulin pump$25,395
Minimed 670G System$397
t:slim X2 Insulin Pump with Control-IQ$216

How this compares

$82,686 in reported general payments places this provider in the 90th percentile of 168 pediatric endocrinology providers in California.

See all pediatric endocrinology providers in California →

Other pediatric endocrinology in Santa Barbara

Zohreh Kousha ShoarSanta Barbara$3K
Gnanagurdasan PrakasamSacramento$805K
Swati ElchuriVentura$210K
Karen KleinSan Diego$195K
Francine KaufmanLos Angeles$184K
Lynda PolgreenOrange$167K
Kevin KaisermanWest Covina$150K
Amrit BhangooLong Beach$140K
Mitchell GeffnerLos Angeles$129K
Stephen GitelmanSan Francisco$105K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →